Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality.
Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality.
复制标题
DOI:
10.1158/0008-5472.can-08-0636
复制
发表时间:
2008-08-01
期刊:
影响因子:
11.2
通讯作者:
Zheng W
中科院分区:
文献类型:
--
作者:
Beeghly-Fadiel A;Long JR;Gao YT;Li C;Qu S;Cai Q;Zheng Y;Ruan ZX;Levy SE;Deming SL;Snoddy JR;Shu XO;Lu W;Zheng W
Matrix metalloproteinase-7 (MMP-7) is a small secreted proteolytic enzyme with broad substrate specificity against extracellular matrix (ECM) and non-ECM components. Known to be vital for tumor invasion and metastasis, accumulating evidence also implicates MMP-7 in cancer development. Using data from the Shanghai Breast Cancer Study (SBCS), we conducted a two-stage study to evaluate the association of MMP-7 single nucleotide polymorphisms (SNPs) with breast cancer risk. Additionally, associated SNPs were characterized by laboratory assays. In Stage 1, 11 SNPs were genotyped among 1,079 incident cases and 1,082 community controls using an Affymetrix Genotyping System. Promising SNPs were selected for Stage 2 evaluation and genotyped by TaqMan allelic discrimination assays in an independent set of 1,911 cases and 1,811 controls. Three SNPs were selected for Stage 2 validation (rs880197, rs10895304, and rs12184413); one had highly consistent results between the two stages of the study. In combined analysis, homozygosity for the variant T allele for rs12184413 was associated with an odds ratio of 0.7 (95% CI: 0.6–0.9) compared to the common C allele. This effect was slightly more pronounced in postmenopausal women (OR: 0.6, 95% CI: 0.4–0.8) than in pre-menopausal women (OR: 0.8, 95% CI: 0.6–1.1). This SNP is located 3′ of the MMP-7 gene, in an area enriched with CTCF binding sites. In silico analysis suggested a regulatory role for this region, and our in vitro assays demonstrated an allelic difference in nuclear protein binding capacity. Results from our study suggest that common MMP-7 genetic polymorphisms may contribute to breast cancer susceptibility.